FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4550611000001107: Naprosyn 125mg/5ml suspension (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17888901000001116 Naprosyn 125mg/5ml suspension (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38432201000001119 Naprosyn 125mg/5ml oral suspension (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Is a Product containing precisely naproxen 25 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has active ingredient Naproxen false Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Is a Naprosyn true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has specific active ingredient Naproxen true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naprosyn 125mg/5ml suspension (Roche Products Ltd) 240 ml Is pack of False Naprosyn 125mg/5ml suspension (Roche Products Ltd) Inferred relationship Existential restriction modifier
Naprosyn 125mg/5ml suspension (Roche Products Ltd) 240 ml Has AMP True Naprosyn 125mg/5ml suspension (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start